Categories: News

Edison Issues Report on Topps Tiles (TPT)

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

London, United Kingdom–(Newsfile Corp. – August 5, 2024) – Edison issues report on Topps Tiles (LSE: TPT).

Topps Tiles is the market-leading specialist retailer/distributor of wall and floor tiles, and associated products, such as tools, grouts and adhesives, to its retail, trade and commercial customers in the UK.

Topps Tiles’ (TPT’s) updated medium-term strategy is focused on leveraging its core competitive strengths into much larger addressable markets, while continuing to grow its core brands and services, which are at various stages of development.

Click here to read the full report.

All reports published by Edison are available to download free of charge from its website 
www.edisongroup.com.

Edison is authorised and regulated by the Financial Conduct Authority.

Edison is not an adviser or broker-dealer and does not provide investment advice. Edison’s reports are not solicitations to buy or sell any securities.

For more information, please contact Edison:

enquiries@edisongroup.com

Russell Pointon +44 (0)20 3077 5700

Connect with Edison on:

LinkedIn www.linkedin.com/company/edison-group-/
X www.x.com/edison_inv_res
YouTube www.youtube.com/edisonitv

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/218815

Staff

Recent Posts

Red Light Holland Receives Initial Third-Party Psilocybin Testing Results via FDA-Compliant, DEA-Registered Partner, Irvine Labs

Initial testing results confirm psilocybin potency and process validation for potential medical grade manufacturing applicationsIrvine…

22 minutes ago

Elucent Medical Launches SmartSupport™ – A Smarter Standard in Surgical Support 

MINNEAPOLIS, Aug. 18, 2025 (GLOBE NEWSWIRE) -- Elucent Medical is proud to announce the launch…

23 minutes ago

Capricor Therapeutics Announces First Subjects Dosed in Phase 1 Clinical Trial of Novel Exosome-Based Vaccine

First-in-human trial of Capricor’s StealthX™ vaccine initiated under HHS’s Project NextGenTrial conducted and funded by…

23 minutes ago

Press Release Biocartis NV: Biocartis Welcomes Mike Kreitzinger as Senior Vice President of Global Business Development

PRESS RELEASE - 08/18/2025, 09:00 AM EDT Biocartis Welcomes Mike Kreitzinger as Senior Vice President…

23 minutes ago